journal article·2024-11Open access

Hormonally and chemically defined expansion conditions for organoids of biliary tree Stem Cells

Wencheng Zhang, Yangyang Cui, Mengqi Lu, Mingyang Xu, Yuting Li, Haimeng Song, Yi Luo, Jinjia Song, Yong Yang, Xicheng Wang, Lijun Liao, Yunfang Wang, Lola Reid, Zhiying He

Abstract

Wholly defined ex vivo expansion conditions for biliary tree stem cell (BTSC) organoids were established, consisting of a defined proliferative medium (DPM) used in combination with soft hyaluronan hydrogels. The DPM consisted of commercially available Kubota's Medium (KM), to which a set of small molecules, particular paracrine signals, and heparan sulfate (HS) were added. The small molecules used were DNA methyltransferase inhibitor (RG108), TGF- β Type I receptor inhibitor (A83-01), adenylate cyclase activator (Forskolin), and L-type Ca 2+ channel agonist (Bay K8644). A key paracrine signal proved to be R-spondin 1 (RSPO1), a secreted protein that activates Wnts. Soluble hyaluronans, 0.05 % sodium hyaluronate, were used with DPM to expand monolayer cultures. Expansion of organoids was achieved by using DPM in combination with embedding organoids in Matrigel that was replaced with a defined thiol-hyaluronan triggered with PEGDA to form a hydrogel with a rheology [ G* ] of less than 100 Pa. The combination is called the BTSC-Expansion-Glycogel-System (BEX-gel system) for expanding BTSCs as a monolayer or as organoids. The BTSC organoids were expanded more than 3000-fold ex vivo in the BEX-gel system within 70 days while maintaining phenotypic traits indicative of stem/progenitors. Stem-cell-patch grafting of expanded BTSC organoids was performed on the livers of Fah -/- mice with tyrosinemia and resulted in the rescue of the mice and restoration of their normal liver functions. The BEX-gel system for BTSC organoid expansion provides a strategy to generate sufficient numbers of organoids for the therapeutic treatments of liver diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Liver physiology and pathology · Pancreatic function and diabetes · Proteoglycans and glycosaminoglycans research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. Biliary tree stem/progenitor cells in glands of extrahepatic and intrahepatic bile ducts: an anatomical in situ study yielding evidence of maturational lineages10.1111/j.1469-7580.2011.01462.x ↗
2. Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for life-long pancreatic organogenesis Stem cells
3. Patch grafting, strategies for transplantation of organoids into solid organs such as liver10.1016/j.biomaterials.2021.121067 ↗
4. A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans10.1038/s41536-023-00303-5 ↗
5. Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states10.1016/j.biomaterials.2022.121647 ↗
6. Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis10.1186/s12876-014-0204-z ↗
7. Management of hyperbilirubinemia in biliary atresia by hepatic progenitor cell transplantation through hepatic artery: a case report10.1016/j.transproceed.2008.03.110 ↗
8. Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia10.1016/j.transproceed.2008.03.022 ↗
9. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis10.3727/096368909X484707a ↗
10. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigens
11. Identification and characterization of vitamin A-storing cells in fetal liver: implications for functional importance of hepatic stellate cells in liver development and hematopoiesis10.1634/stemcells.2006-0316 ↗
12. Regulation of hepatic stem/progenitor phenotype by microenviroment stiffness in hydrogel models of the human liver stem cell niche10.1016/j.biomaterials.2011.06.042 ↗
13. Culture conditions and single growth factors affect fate determination of mouse spermatogonial stem cells10.1095/biolreprod.104.029207 ↗
14. Successful transplantation of human hepatic stem cells with restricted localization to liver using hyaluronan grafts10.1002/hep.26065 ↗
15. Lineage-dependent epithelial-mesenchymal paracrine signals dictate growth versus differentiation of human hepatic stem cells to adult fates10.1002/hep.23829 ↗
16. Matrigel: from discovery and ECM mimicry to assays and models for cancer research10.1016/j.addr.2014.06.005 ↗
17. Matrigel: a complex protein mixture required for optimal growth of cell culture10.1002/pmic.200900758 ↗
18. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma10.1021/bi00267a025 ↗
19. Characterization of a novel glycoprotein isolated from the basement membrane matrix of the Engelbreth-Holm-Swarm tumor10.1016/S0021-9258(18)83710-3 ↗
20. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin10.1016/0092-8674(90)90176-F ↗
21. Synthetic alternatives to matrigel10.1038/s41578-020-0199-8 ↗
22. Organoids, where we stand and where we go10.1016/j.molmed.2021.03.001 ↗
23. Non-matrigel scaffolds for organoid cultures10.1016/j.canlet.2021.01.025 ↗
24. Towards organoid culture without Matrigel10.1038/s42003-021-02910-8 ↗
25. Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine10.1080/07388551.2021.1932716 ↗
26. Chemical, molecular, and single-nucleus analysis reveal chondroitin sulfate proteoglycan aberrancy in fibrolamellar carcinoma10.1158/2767-9764.CRC-21-0177 ↗
27. Human hepatoblast phenotype maintained by hyaluronan hydrogels10.1002/jbm.b.30717 ↗
28. Stem/progenitor cell niches involved in hepatic and biliary regeneration
29. Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets10.1002/hep.24590 ↗
30. Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder10.1016/j.jhep.2014.01.026 ↗
31. Fibrolamellar carcinomas-growth arrested by paracrine signals complexed with synthesized 3-O sulfated heparan sulfate oligosaccharides10.1016/j.matbio.2023.06.008 ↗
32. A MicroRNA-based network provides potential predictive signatures and reveals the crucial role of PI3K/AKT signaling for hepatic lineage maturation
33. Progenitor cell niches in the human pancreatic duct system and associated pancreatic duct glands: an anatomical and immunophenotyping study10.1111/joa.12418 ↗
34. Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential10.1016/j.jhep.2022.08.037 ↗
35. Conversion of human gastric epithelial cells to multipotent endodermal progenitors using defined small molecules10.1016/j.stem.2016.06.006 ↗
36. Human embryonic stem cell–derived hepatoblasts are an optimal lineage stage for hepatitis C virus infection10.1002/hep.29134 ↗
37. Stem cell‐fueled maturational lineages in hepatic and pancreatic organogenesis10.1002/9781119436812.ch42 ↗
38. Molecular diversity of heparan sulfate10.1172/JCI200113530 ↗
39. Construction and characterization of heparan sulfate heptasaccharide microarray10.1039/C6CC08204A ↗
40. The good the bad and the ugly of glycosaminoglycans in tissue engineering applications10.3390/ph10020054 ↗
41. Couchman · 2016
42. Order out of chaos: assembly of ligand binding sites in heparan sulfate10.1146/annurev.biochem.71.110601.135458 ↗
43. The heparanome--the enigma of encoding and decoding heparan sulfate sulfation10.1016/j.jbiotec.2007.01.022 ↗
44. The function of heparan sulfate during branching morphogenesis10.1016/j.matbio.2016.09.004 ↗
45. Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulation10.1016/j.mce.2014.09.011 ↗
46. Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate10.1016/j.sbi.2018.04.003 ↗
47. Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering10.1002/mabi.200800141 ↗
48. Direct chemical induction of hepatocyte-like cells with capacity for liver repopulation10.1002/hep.32686 ↗
49. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages10.1016/j.stem.2014.01.006 ↗
50. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming10.1016/j.tips.2009.10.002 ↗
51. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct410.1016/j.celrep.2014.01.038 ↗
52. Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection10.1093/cvr/cvac085 ↗
53. Forskolin-driven conversion of human somatic cells into induced neurons through regulation of the cAMP-CREB1-JNK signaling10.7150/thno.92700 ↗
54. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques10.1038/s41551-018-0275-1 ↗
55. 3D hydrogel encapsulation regulates nephrogenesis in kidney organoids10.1002/adma.202308325 ↗
56. Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure10.1016/j.stem.2024.02.005 ↗
57. A scalable culture system incorporating microcarrier for specialised mesenchymal stem cells from human embryonic stem cells10.1016/j.mtbio.2023.100662 ↗
58. In situ pocket-type microcarrier (PMc) as a therapeutic composite: regeneration of cartilage with stem cells, genes, and drugs10.1016/j.jconrel.2020.08.057 ↗
59. Microcarriers promote the through interface movement of mouse trophoblast stem cells by regulating stiffness
60. HYDRHA: hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering10.1016/j.mtbio.2022.100453 ↗
61. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives10.1016/S0168-3659(97)00242-3 ↗
62. Physical properties of glycosaminoglycan hydrogels10.1002/polb.20299 ↗
63. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery10.1016/S0168-3659(00)00300-X ↗
64. Novel hydrogels of hyaluronic acid: synthesis, surface morphology, and solid-state NMR10.1021/ja00096a007 ↗
65. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering
66. Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis10.1152/ajpgi.00254.2021 ↗
67. Cells-Grab-on particles: a novel approach to control cell focal adhesion on hybrid thermally annealed hydrogels10.1021/acsbiomaterials.0c00119 ↗
68. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan10.1016/S0021-9258(17)38421-1 ↗
69. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans10.1016/S0021-9258(18)61150-0 ↗
70. Heparan sulfate 3-O-sulfation: a rare modification in search of a function10.1016/j.matbio.2013.12.001 ↗
71. Analysis of 3-O-sulfated heparan sulfate using isotopically labeled oligosaccharide calibrants10.1021/acs.analchem.1c04965 ↗
72. Investigation of the biological functions of heparan sulfate using a chemoenzymatic synthetic approach10.1039/D0CB00199F ↗
73. Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases10.1016/j.devcel.2014.04.024 ↗
74. Concise review: clinical programs of stem cell therapies for liver and pancreas10.1002/stem.1457 ↗
75. Hepatic stem cells and hepatoblasts: identification, isolation and ex vivo maintenance Methods for Cell Biology (Methods for Stem Cells)